Human Osteoarthritic Chondrocytes Express Nineteen Different TRP-Genes-TRPA1 and TRPM8 as Potential Drug Targets.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
13 Jun 2023
Historique:
received: 15 04 2023
revised: 01 06 2023
accepted: 07 06 2023
medline: 29 6 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: epublish

Résumé

Transient receptor potential (TRP) ion channels are expressed in neuronal and some non-neuronal cells and are involved particularly in pain and thermosensation. We previously showed that TRPA1 is functionally expressed in human osteoarthritic (OA) chondrocytes and mediates inflammation, cartilage degradation, and pain in monosodium-iodoacetate-induced experimental OA. In the present study, we explored the expression of TRP-channels in primary human OA chondrocytes and investigated whether drugs used in the treatment of OA, ibuprofen and glucocorticoids, have effects on TRP-channel expression. OA cartilage was obtained from knee replacement surgery and chondrocytes were isolated with enzyme digestion. NGS analysis showed the expression of 19 TRP-genes in OA chondrocytes, with TRPM7, TRPV4, TRPC1, and TRPM8 having the highest counts in unstimulated cells. These results were verified with RT-PCR in samples from a different group of patients. Interleukin-1β (IL-1β) significantly increased TRPA1 expression, while TRPM8 and TRPC1 expression was decreased, and TRPM7 and TRPV4 expression remained unaffected. Furthermore, dexamethasone attenuated the effect of IL-1β on TRPA1 and TRPM8 expression. The TRPM8 and TRPA1 agonist menthol increased the expression of the cartilage-degrading enzymes MMP-1, MMP-3, and MMP-13 and the inflammatory factors iNOS and IL-6 in OA chondrocytes. In conclusion, human OA chondrocytes express 19 different TRP-genes, of which the significant TRPM8 expression is a novel finding. Dexamethasone attenuated IL-1β-induced TRPA1 expression. Interestingly, the TRPM8 and TRPA1 agonist menthol increased MMP expression. These results support the concept of TRPA1 and TRMP8 as potential novel drug targets in arthritis.

Identifiants

pubmed: 37373205
pii: ijms241210057
doi: 10.3390/ijms241210057
pmc: PMC10298562
pii:
doi:

Substances chimiques

TRPM Cation Channels 0
TRPV Cation Channels 0
Menthol 1490-04-6
TRPA1 Cation Channel 0
Transient Receptor Potential Channels 0
Dexamethasone 7S5I7G3JQL
TRPA1 protein, human 0
TRPM7 protein, human EC 2.7.11.1
Protein Serine-Threonine Kinases EC 2.7.11.1
TRPM8 protein, human 0
TRPM8 channel-associated factor 1 protein, human 0
Membrane Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Competitive research funding (VTR funding) from the Tampere University Hospital, Tampere, Finland.
ID : na

Références

Nat Rev Drug Discov. 2009 Jan;8(1):55-68
pubmed: 19116627
Biochem Biophys Res Commun. 2019 Aug 27;516(3):825-830
pubmed: 31262448
J Neurosci. 2007 Sep 12;27(37):9874-84
pubmed: 17855602
Front Pharmacol. 2022 May 24;13:914499
pubmed: 35685622
J Pharm Pharm Sci. 2010;13(2):242-53
pubmed: 20816009
J Biol Chem. 2007 Nov 2;282(44):32158-67
pubmed: 17804410
BMB Rep. 2020 Mar;53(3):125-132
pubmed: 32172727
Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9652-6
pubmed: 7568191
Nat Commun. 2020 Jul 29;11(1):3790
pubmed: 32728032
Osteoarthritis Cartilage. 2015 Nov;23(11):2017-26
pubmed: 26521748
J Pers Med. 2021 Feb 08;11(2):
pubmed: 33567636
Lancet. 2019 Apr 27;393(10182):1745-1759
pubmed: 31034380
Arthritis Care Res (Hoboken). 2020 Feb;72(2):149-162
pubmed: 31908149
Int J Mol Sci. 2018 Apr 25;19(5):
pubmed: 29693628
Nature. 2001 May 31;411(6837):590-5
pubmed: 11385574
Int J Mol Sci. 2021 Aug 31;22(17):
pubmed: 34502384
Nat Rev Drug Discov. 2022 Jan;21(1):41-59
pubmed: 34526696
Int J Mol Sci. 2020 Dec 23;22(1):
pubmed: 33374841
Eur J Pharmacol. 2014 Feb 15;725:1-9
pubmed: 24440691
Arthritis Rheum. 2010 Oct;62(10):2973-83
pubmed: 20583100
RMD Open. 2021 Sep;7(3):
pubmed: 34497153
Arthritis Res Ther. 2016 Aug 11;18(1):185
pubmed: 27515912
RMD Open. 2017 Sep 4;3(2):e000556
pubmed: 28912961
Science. 2001 Feb 9;291(5506):1043-7
pubmed: 11161216
Nature. 1969 Oct 18;224(5216):285-7
pubmed: 5344615
Mol Cell Biochem. 2009 Jan;321(1-2):135-43
pubmed: 18836817
Br J Dermatol. 2019 May;180(5):1030-1038
pubmed: 30623408

Auteurs

Leevi Halonen (L)

The Immunopharmacology Research Group, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, 33014 Tampere, Finland.

Antti Pemmari (A)

The Immunopharmacology Research Group, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, 33014 Tampere, Finland.

Elina Nummenmaa (E)

The Immunopharmacology Research Group, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, 33014 Tampere, Finland.

Mari Hämäläinen (M)

The Immunopharmacology Research Group, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, 33014 Tampere, Finland.

Teemu Moilanen (T)

The Immunopharmacology Research Group, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, 33014 Tampere, Finland.
Coxa Hospital for Joint Replacement, 33520 Tampere, Finland.

Katriina Vuolteenaho (K)

The Immunopharmacology Research Group, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, 33014 Tampere, Finland.

Eeva Moilanen (E)

The Immunopharmacology Research Group, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, 33014 Tampere, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH